News
September 28, 2026
IR
Supplementary Materials of FY26 Q4 Consolidated Financial Results 
September 17, 2026
IR
【Correction of Numerical Data】Consolidated Financial Results for the Fiscal Year Ended July 31, 2026 (Under Japanese GAAP)
September 11, 2026
IR
[Summary]Consolidated Financial Results for the Fiscal Year Ended July 31, 2026 (Under Japanese GAAP)
September 9, 2026
IR
Notice Regarding Special Loss (non-consolidated) due to Impairment of Investment in an Equity-Method Affiliate
September 9, 2026
IR
Notice Regarding Revision of Full-Year Financial Results Forecast for the Fiscal Year Ended July 2026
June 10, 2026
IR
Supplementary Materials of FY26 Q3 Consolidated Financial Results
June 10, 2026
IR
[Summary] Consolidated Financial Results for the Nine Months Ended April 30, 2026 (Under Japanese GAAP)
April 30, 2026
R&D
PharmaGABA® New Scientific Study Published in Leading International Journal - Accelerating Global Expansion and Adoption in the Food & Beverage Category -
April 22, 2026
Media
Pharma Foods Certified as 2026 Health & Productivity Management Outstanding Organization ― Fourth consecutive year of recognition; Group-wide commitment to "KENKO Investment" ―
April 6, 2026
R&D
Pharma Foods Co., Ltd. Acquires Exclusive Rights to Advance First-in-Class Adrenomedullin Program for CADASIL Across Key Asian Markets
September 17, 2026
IR
【Correction of Numerical Data】Consolidated Financial Results for the Fiscal Year Ended July 31, 2026 (Under Japanese GAAP)
September 11, 2026
IR
[Summary]Consolidated Financial Results for the Fiscal Year Ended July 31, 2026 (Under Japanese GAAP)
September 9, 2026
IR
Notice Regarding Special Loss (non-consolidated) due to Impairment of Investment in an Equity-Method Affiliate
September 9, 2026
IR
Notice Regarding Revision of Full-Year Financial Results Forecast for the Fiscal Year Ended July 2026
June 10, 2026
IR
Supplementary Materials of FY26 Q3 Consolidated Financial Results
June 10, 2026
IR
[Summary] Consolidated Financial Results for the Nine Months Ended April 30, 2026 (Under Japanese GAAP)
April 30, 2026
R&D
PharmaGABA® New Scientific Study Published in Leading International Journal - Accelerating Global Expansion and Adoption in the Food & Beverage Category -
April 22, 2026
Media
Pharma Foods Certified as 2026 Health & Productivity Management Outstanding Organization ― Fourth consecutive year of recognition; Group-wide commitment to "KENKO Investment" ―
April 6, 2026
R&D
Pharma Foods Co., Ltd. Acquires Exclusive Rights to Advance First-in-Class Adrenomedullin Program for CADASIL Across Key Asian Markets